FluGen Revenue and Competitors
Estimated Revenue & Valuation
- FluGen's estimated annual revenue is currently $2.3M per year.
- FluGen's estimated revenue per employee is $178,846
- FluGen's total funding is $71.4M.
Employee Data
- FluGen has 13 Employees.
- FluGen grew their employee count by -7% last year.
FluGen's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Founder, President & CEO | Reveal Email/Phone |
2 | VP R&D Operations | Reveal Email/Phone |
3 | Data & Interactive Media Manager | Reveal Email/Phone |
4 | Senior Scientist | Reveal Email/Phone |
FluGen Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $2.8M | 18 | 20% | N/A | N/A |
#2 | $1.9M | 12 | 33% | N/A | N/A |
#3 | $1.1M | 7 | 0% | N/A | N/A |
#4 | $0.9M | 6 | 0% | N/A | N/A |
#5 | $5.2M | 67 | 0% | $45.5M | N/A |
#6 | $1.4M | 9 | 0% | N/A | N/A |
#7 | $1.6M | 10 | 0% | N/A | N/A |
#8 | $1.1M | 7 | 17% | N/A | N/A |
#9 | $13.5M | 87 | -17% | N/A | N/A |
#10 | $0.6M | 4 | -20% | N/A | N/A |
What Is FluGen?
With eight employees, FluGen was founded in 2007 and received initial support from angel investors and other sources including WARF. Based in the University Research Park in Madison, its first product to enter clinical trials will be the vaccine delivery patch. The market for influenza products alone was estimated at more than $6 billion for 2010.
keywords:N/A
$71.4M
Total Funding
13
Number of Employees
$2.3M
Revenue (est)
-7%
Employee Growth %
N/A
Valuation
N/A
Accelerator
FluGen News
... single-replication, intranasal flu vaccine based on an invention by UW Madison virologists and FluGen co-founders Yoshihiro Kawaoka,...
MADISON, Wis., Aug. 2, 2021 /PRNewswire/ -- FluGen, Inc., a clinical-stage vaccine company transforming vaccine efficacy in infectious respiratory diseases, today announced the publication of results from its Phase 2 human challenge study of Bris2007 M2SR, the Company's investigational, supra- ...
MADISON, Wis., May 25, 2021 /PRNewswire/ -- FluGen, Inc., a clinical-stage vaccine company transforming vaccine efficacy in infectious respiratory diseases, today announced the initiation of the first study in older adults of M2SR, the company's investigational supra-seasonal, live, single-rep ...
FluGen Inc., a Madison, WI-based biotechnology company developing a novel “universal” influenza vaccine, completed a $12m Series A financing. Backers included Venture Investors LLC, the Wisconsin Alumni Research Foundation (WARF), the State of Wisconsin Investment Board, and other new and exist ...
Other Companies in Madison
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $1.1M | 13 | 18% | N/A |
#2 | N/A | 13 | -52% | N/A |
#3 | $0.8M | 13 | 18% | N/A |
#4 | $1.6M | 13 | -13% | N/A |
#5 | $2M | 13 | 0% | N/A |